These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 7359272

  • 1. Mycobacterium chelonei septicemia in a premature infant.
    Speert DP, Munson D, Mitchell C, Johnson DE, Thompson TR, Ferrieri P, Wannamaker LW.
    J Pediatr; 1980 Apr; 96(4):681-3. PubMed ID: 7359272
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ, Swenson JM, Silcox VA, Bullen MG.
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [Abstract] [Full Text] [Related]

  • 3. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR, Pankey GA, Wallace RJ, Jones DB.
    Rev Infect Dis; 1981 Sep; 3(5):1068-74. PubMed ID: 7339806
    [Abstract] [Full Text] [Related]

  • 4. Mycobacterium chelonei tenosynovitis.
    Zachary LS, Clark GL, Kleinert JM, O'Donovan C.
    Ann Plast Surg; 1988 Apr; 20(4):360-2. PubMed ID: 3364921
    [Abstract] [Full Text] [Related]

  • 5. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
    Masur H, Tuazon C, Gill V, Grimes G, Baird B, Fauci AS, Lane HC.
    J Infect Dis; 1987 Jan; 155(1):127-9. PubMed ID: 3794396
    [No Abstract] [Full Text] [Related]

  • 6. Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum.
    Garcia-Rodriguez JA, Martin-Luengo F.
    Tubercle; 1978 Dec; 59(4):277-80. PubMed ID: 726085
    [Abstract] [Full Text] [Related]

  • 7. Amikacin treatment for Mycobacterium marinum infection.
    Arai H, Nakajima H, Naito S, Kaminaga Y, Nagai R.
    J Dermatol; 1986 Oct; 13(5):385-9. PubMed ID: 3546444
    [No Abstract] [Full Text] [Related]

  • 8. Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.
    Carpenter JL, Troxell M, Wallace RJ.
    Arch Intern Med; 1984 Oct; 144(10):2063-5. PubMed ID: 6486990
    [Abstract] [Full Text] [Related]

  • 9. Mycobacterium chelonei infection of a corneal graft.
    Aylward GW, Stacey AR, Marsh RJ.
    Br J Ophthalmol; 1987 Sep; 71(9):690-3. PubMed ID: 3311141
    [Abstract] [Full Text] [Related]

  • 10. Mycobacterium chelonei and abscess formation in soft tissues.
    Hanson PJ, Thomas JM, Collins JV.
    Tubercle; 1987 Dec; 68(4):297-9. PubMed ID: 3455569
    [Abstract] [Full Text] [Related]

  • 11. [Sporotrichoid cutaneous infection caused by Mycobacterium chelonei. Cure with minocycline].
    Godard W, Cordier N, Kazmierczak A, Lambert D.
    Presse Med; 1986 Jan 25; 15(3):120. PubMed ID: 2937044
    [No Abstract] [Full Text] [Related]

  • 12. [Contaminated infusions as cause of nosocomial Serratia marcescens septicaemia in children (author's transl)].
    Daschner F, Senska-Euringer C.
    Dtsch Med Wochenschr; 1975 Nov 07; 100(45):2324-8. PubMed ID: 1102282
    [Abstract] [Full Text] [Related]

  • 13. Renal infection with Mycobacterium chelonei.
    Becker GJ, Walker RG, Dziukas LJ, Harvey KJ, Valentine R, Kincaid-Smith P.
    Aust N Z J Med; 1980 Feb 07; 10(1):44-7. PubMed ID: 6929675
    [Abstract] [Full Text] [Related]

  • 14. Mycobacterium chelonei keratitis.
    Meisler DM, Friedlaender MH, Okumoto M.
    Am J Ophthalmol; 1982 Sep 07; 94(3):398-401. PubMed ID: 7124881
    [No Abstract] [Full Text] [Related]

  • 15. Adjunctive surgical management of cutaneous Mycobacterium fortuitum infection.
    Madjar DD, Carvallo E, Proper SA, Fenske NA.
    J Dermatol Surg Oncol; 1985 Jul 07; 11(7):708-12. PubMed ID: 4008739
    [Abstract] [Full Text] [Related]

  • 16. Disseminated Mycobacterium chelonei infection: response to sulfonamides.
    Tice AD, Solomon RJ.
    Am Rev Respir Dis; 1979 Jul 07; 120(1):197-201. PubMed ID: 464378
    [Abstract] [Full Text] [Related]

  • 17. Use of Amikacin in a hospital for children: microbiological and clinical studies.
    Marget W, Reindke B, Versmold H.
    J Infect Dis; 1976 Nov 07; 134 SUPPL():S412-9. PubMed ID: 825592
    [Abstract] [Full Text] [Related]

  • 18. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ, Hull SI, Bobey DG, Price KE, Swenson JM, Steele LC, Christensen L.
    Am Rev Respir Dis; 1985 Aug 07; 132(2):409-16. PubMed ID: 4026065
    [Abstract] [Full Text] [Related]

  • 19. Mycobacterium chelonei keratitis: a case report.
    Mirate DJ, Hull DS, Steel JH, Carter MJ.
    Br J Ophthalmol; 1983 May 07; 67(5):324-6. PubMed ID: 6838806
    [Abstract] [Full Text] [Related]

  • 20. Mycobacterium chelonei infection: successful treatment based on a radiometric susceptibility test.
    Arroyo J, Medoff G.
    Antimicrob Agents Chemother; 1977 Apr 07; 11(4):763-4. PubMed ID: 856032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.